Emerging Markets Quality Trials

Welcome to eMQT where we enable two clear solutions for the pharmaceutical industry:

We stand as a powerhouse where AFRICAN LIVES MATTER! Serving as the unyielding bridge between the pharmaceutical industry and Africa, we leverage the expertise of research healthcare professionals and ground-breaking technological innovation. Our mission is to not only grant access to patients but also to generate high-quality, evidence-based patient data, fuelled by the driving forces of training and education.

We leverage technological innovation to redefine global clinical research. Our transformative, technology-driven solutions play a crucial 
role in optimising the entire drug development lifecycle, from clinical trial preparation to execution. This not only reduces costs but also expedites the development of new treatments for patients.


  • Currently, 95% of cancer patients in Sub-Saharan Africa (SSA) are diagnosed too late.
  • The population offers drug naïve patients in multiple disease areas that are accessible through careful planning and engagement.
  • The ‘Rising Billion’ people in Africa are expected to reach 3-5 billion by 2050 representing half of the world’s population. The rising GDP and consumer power offers an attractive therapeutic market.
  • Although the patients of African descent make up 17% of the world’s population (over 1Billion), Black People are underrepresented in clinical trials globally reported as less than 3% by the Genome-Wide Association Studies (GWAS).


  • Precision Data Collection: Harnessing AI to ensure precise and standardised data collection methods, reducing variability and enhancing the accuracy of clinical trial results.
  • Real-time Monitoring and Insights for Improved Patient Engagement: Implementing AI-driven monitoring systems for real-time monitoring of patient data, enabling proactive intervention, and fostering active patient engagement, and addressing potential barriers, especially in remote or underserved areas of Africa.
  • Automated Document Generation: Leveraging AI for automated document generation, to ensure that trial materials are accessible, consistent, and culturally sensitive, promoting inclusivity and ease of understanding for a diverse range of participants, reducing manual effort, and expediting the regulatory submission process.
  • Enhanced Data Security and Compliance: Leveraging AI technologies for robust data security measures to build trust among patients, ensuring that their data is handled ethically and securely, thereby encouraging diverse participation in clinical trials.
  • Efficient Data Analysis and Reporting: Employing AI algorithms for efficient data analysis, enabling faster identification of trends, potential issues, and insights that contribute to more informed decision-making and streamlined reporting processes.

Our Solutions